Skip to main
23 Followers • 118 Following

Jj

@jkr69
  1. Asset
    Price
  2. CLNN
    Clene Nanomedicine
  3. Nuwellis
  4. ABVC BioPharma
  5. ADC Therapeutics
  6. AEye
  7. AMTD Digital
  8. AMTD International Inc
  9. Accelerate Diagnostics
  10. Aclarion Inc
  11. Actelis Networks Inc
  12. Adamas One Corp
  13. Addex Therapeutics
  14. Adial Pharmaceuticals Inc
  15. Aethlon Medical
  16. Agriforce Growing Systems Ltd
  17. Agrify
  18. Ainos Inc
  19. Akanda Corp
  20. Akoustis Technologies Inc
  21. Alaunos Therapeutics
  22. Alfi Inc
  23. Alignment Healthcare
  24. Alkaline Water Company Inc (The)
  25. Allurion Technologies Holdings Inc
  26. Alset EHome International
  27. Altamira Therapeutics Ltd
  28. Alzamend Neuro
  29. Amarin Corporation Plc
  30. American Lithium Corp
  31. Ampio Pharmaceuticals Inc
  32. Amprius Technologies Inc
  33. Applied UV Inc
  34. Appreciate Holdings Inc
  35. Aprea Therapeutics
  36. Aptevo Therapeutics
  37. Aptose Biosciences
  38. Aqua Metals
  39. Ardelyx
  40. Aridis Pharmaceuticals
  41. Arrival SA
  42. Artelo Biosciences Inc
  43. Assertio Therapeutics Inc
  44. Astrotech
  45. Athersys Inc
  46. Atlantic International Corp
  47. Austin Gold Corp
  48. Avino Silver & Gold Mines
  49. Aytu BioScience
  50. BIT Mining Limited
  51. Baudax Bio Inc
  52. Biolase Inc
  53. Bioline RX
  54. Bionano Genomics
  55. Biophytis SA
  56. Biora Therapeutics Inc
  57. Biosig Technologies Inc
  58. Bit Digital, Inc
  59. Bit Origin Ltd
  60. Bitcoin Depot Inc
  61. Bitfarms Ltd
  62. Bitwise Crypto Innovators ETF
  63. Blue Owl Capital Corp
  64. Blue Star Foods Corp
  65. Bluejay Diagnostics
  66. Bone Biologics Corp
  67. Borqs Technologies Inc
  68. Boxlight
  69. Brainstorm Cell Therapeutics
  70. Bridger Aerospace Group Holdings Inc
  71. Bright Green Corp
  72. Bruush Oral Care Inc
  73. C3is Inc
  74. CN Energy Group
  75. CS Disco
  76. CXApp Inc
  77. Camber Energy Inc
  78. Can-Fite BioPharma Ltd.
  79. Canoo
  80. Cardio Diagnostics Holdings In
  81. Carisma Therapeutics Inc
  82. Cartesian Therapeutics Inc
  83. Catheter Precision Inc
  84. Cazoo Group Ltd
  85. Cellectar BioSciences
  86. Celularity
  87. Cemtrex
  88. Cenntro Inc
  89. China Pharma Holdings
  90. Cineverse Corp
  91. Cipher Mining
  92. CleanSpark
  93. ClearOne
  94. Clearmind Medicine Inc
  95. Clever Leaves Holdings Inc
  96. Cloopen Group Holding Limited
  97. Coinbase
  98. ComSovereign Holding
  99. Comera Life Sciences Holdings Inc
  100. ContraFect Corp
  101. Cosmos Holdings
  102. Courtside Group Inc
  103. Crown Lng Holdings Ltd
  104. Cue Biopharma
  105. Cuentas
  106. Cybin
  107. Cyclacel Pharmaceuticals
  108. DMK Pharmaceuticals Corp
  109. Dermata Therapeutics
  110. Desktop Metal
  111. Digital Brands Group Inc
  112. Document Security Systems
  113. E-Home Household Service Holdings Ltd
  114. ESS Tech
  115. EZGO Technologies
  116. Eastside Distilling
  117. Ebang International Holdings
  118. Eightco Holdings Inc
  119. Electra Battery Materials Corp
  120. Elevation Oncology
  121. Elicio Therapeutics Inc
  122. Enel Chile
  123. Enservco
  124. Ensysce Biosciences
  125. Entero Therapeutics Inc
  126. Enzo Biochem
  127. Esports Entertainment Group
  128. Esports Technologies
  129. Etao International Co Ltd
  130. Evofem Biosciences Inc
  131. Evogene
  132. FOXO Technologies Inc.
  133. Femto Technologies Inc.
  134. Finch Therapeutics Group
  135. First Republic Bank
  136. Flora Growth Corp
  137. Forge Global Holdings Inc
  138. Freight Technologies Inc
  139. Fresh Tracks Therapeutics Inc
  140. Freshworks
  141. Fuel Tech
  142. Future FinTech Group
  143. G Medical Innovations Holdings Ltd
  144. GRI Bio Inc
  145. GSI Technology
  146. Gelesis Holdings Inc
  147. Genesis Energy
  148. Genesis Growth Tech Acquisition Corp
  149. Genius Group Ltd
  150. Geovax Labs
  151. Getaround Inc
  152. Gevo
  153. Gigacloud Tech
  154. Ginkgo Bioworks Holdings
  155. Global X Lithium & Battery Tech ETF
  156. GlucoTrack Inc
  157. GlycoMimetics
  158. Gold Resource
  159. Golden Minerals Company
  160. Gorilla Technology Group Inc
  161. Granite Ridge Resources Inc
  162. Grindr Inc
  163. Grove Collaborative Holdings
  164. Gryphon Digital Mining Inc
  165. Guardforce AI Co Ltd
  166. HTG Molecular Diagnostics Inc
  167. Hall of Fame Resort & Entertainment
  168. Heliogen
  169. Helius Medical Technologies
  170. Hoth Therapeutics
  171. Hub Cyber Security Ltd
  172. Hyperscale Data Inc
  173. HyreCar Inc
  174. Hyzon Motors
  175. IAMGOLD
  176. IM Cannabis Corp
  177. IN8BIO
  178. Ideanomics Inc
  179. Imac Holdings Inc
  180. Immersion
  181. InMed Pharmaceuticals
  182. Inhibikase Therapeutics
  183. Jaguar Health
  184. Jeffs Brands Ltd
  185. Kalera PLC
  186. Kartoon Studios Inc
  187. Kineta Inc
  188. Kiora Pharmaceuticals
  189. Knightscope
  190. Know Labs Inc
  191. Leafly Holdings
  192. Lexicon Pharmaceuticals
  193. Liberty TripAdvisor Hlds
  194. Lightning eMotors Inc
  195. Lion Electric Co
  196. Logistic Properties Of The Americas
  197. Lottery.com
  198. Lucy Scientific Discovery Inc
  199. Lufax Holding
  200. MAIA Biotechnology Inc
  201. MEI Pharma
  202. Mangoceuticals Inc
  203. MedAvail Holdings Inc
  204. Medicenna Therapeutics Corp
  205. MicroVision
  206. Micromobility.com Inc
  207. Milestone Pharmaceuticals Inc
  208. Milestone Scientific
  209. Minerva Surgical
  210. Missfresh Ltd
  211. Mobile Global Esports Inc
  212. Motus GI Hlds
  213. Mountain Crest Acquisition Corp II
  214. N2OFF Inc
  215. NAYA Biosciences Inc
  216. NIO
  217. Nabriva Therapeutics PLC
  218. NanoVibronix
  219. Navidea Biopharma
  220. Neptune Wellness Solutions Inc
  221. NeuroOne Medical Technologies Corp
  222. Neuronetics Inc
  223. Next Technology Holding Inc
  224. NextPlay Technologies
  225. Nocera Inc
  226. Notable Labs Ltd
  227. NuCana
  228. Nxu Inc
  229. Nymox Pharmaceutical Corp
  230. ObsEva SA
  231. OceanPal
  232. Olo
  233. OncoCyte
  234. Ontrak
  235. Oragenics
  236. Orchid Island Capital
  237. OrganiGram Holdings Inc.
  238. Ostin Technology Group Co Ltd
  239. Owlet
  240. PLBY Group
  241. Palisade Bio
  242. Panbela Therapeutics Inc
  243. Performance Shipping
  244. Petros Pharmaceuticals
  245. Plug Power
  246. Plus Therapeutics Inc
  247. Polar Power
  248. Polished.com Inc
  249. PolyPid
  250. Predictive Oncology Inc
  251. Presto Automation Inc
  252. ProShares Bitcoin Strategy ETF
  253. Qualigen Therapeutics
  254. Quoin Pharmaceuticals Ltd
  255. REE Automotive Ltd
  256. RedHill Biopharma
  257. Reed's
  258. Regenetp Inc
  259. Rein Therapeutics Inc
  260. Remark Hlds
  261. RiskOn International Inc
  262. Rubicon Technologies Inc
  263. SAB Biotherapeutics
  264. SAIHEAT Ltd
  265. SG Blocks
  266. SMX
  267. SQL Technologies Corp
  268. SRM Entertainment Inc
  269. Salarius Pharmaceuticals Inc
  270. SaverOne 2014 Ltd
  271. SciSparc Ltd
  272. Scorpius Holdings Inc
  273. Secoo Holding Ltd
  274. Selina Hospitality PLC
  275. Senseonics Holdings
  276. Sharing Services Global Corp
  277. Sharplink Gaming Inc
  278. Sharps Technology Inc
  279. Shuttle Pharmaceuticals Holdings Inc
  280. Signature Bank
  281. Silvergate Capital Corp
  282. Skillz
  283. SmileDirectClub Inc
  284. Snail Inc
  285. Sonnet BioTherapeutics
  286. Sono Group NV
  287. Sonoma Pharmaceuticals
  288. Sorrento Therapeutics Inc
  289. Sphere 3D
  290. Statera Biopharma Inc
  291. Stryve Foods
  292. Summit Wireless Technologies Inc
  293. Super League Enterprise Inc
  294. Synaptogenix
  295. Synlogic
  296. T2 Biosystems
  297. TNF Pharmaceuticals Inc
  298. TOP Ships
  299. Talphera Inc
  300. Tantech Hlds
  301. Taoping Inc.
  302. Tempo Automation Holdings Inc
  303. The Oncology Institute
  304. Theriva Biologics Inc
  305. Tivic Health Systems
  306. Tonix Pharmaceuticals Hld
  307. TransCode Therapeutics
  308. TuSimple Holdings Inc.
  309. Turkcell Iletisim Hizmetleri A.S.
  310. TurnOnGreen Inc
  311. TurnOnGreen, Inc
  312. Unique Fabricating Inc
  313. UpHealth Inc
  314. Uxin Ltd - ADR
  315. VIQ Solutions Inc
  316. VIZSLA ROYALTIES CORP.
  317. Venus Concept
  318. Verastem
  319. Verb Technology Company Inc
  320. Versus Systems
  321. Vicarious Surgical
  322. ViewRay Inc
  323. Vinco Ventures
  324. Vyne Therapeutics
  325. Waitr Holdings Inc
  326. Wearable Devices Ltd
  327. X3 Holdings Co Ltd
  328. XTI Aerospace Inc
  329. Xos
  330. Xylo Technologies Ltd
  331. Zhong Yang Financial Group Ltd
  332. Zovio Inc
  333. bioAffinity Technologies Inc
  334. bluebird bio
  335. cbdMD Inc
  336. iShares Bitcoin Trust
  337. mCloud Technologies Corp
  1. Asset
    Price
  2. ANGI Homeservices
  3. Advanced Health Intelligence
  4. Advent Technologies Holdings
  5. AdvisorShares Pure Cannabis ETF
  6. Affimed

Invest in everything on Public

Public is an all-in-one investing platform where you can build a multi-asset portfolio that includes everything from stocks and options to bonds, crypto, and a High-Yield Cash Account.
Sign Up
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2025 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Stocks, ETFs, Options, Bonds.
Self-directed brokerage accounts and brokerage services for US-listed, registered securities, options, and Bonds, except for treasury securities offered through Jiko Securities, Inc., are offered to self-directed customers by Open to the Public Investing, Inc. (“Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Public Investing is not registered. Securities products offered by Public Investing are not FDIC insured. Apex Clearing Corporation, our clearing firm, has additional insurance coverage in excess of the regular SIPC limits. Additional information can be found here.

Options.
Certain requirements must be met in order to trade options. Options can be risky and are not suitable for all investors. Options transactions are often complex, and investors can rapidly lose the entire amount of their investment or more in a short period of time. Investors should consider their investment objectives and risks carefully before investing in options. Refer to the Characteristics and Risks of Standardized Options before considering any options transaction. Supporting documentation for any claims, if applicable, will be furnished upon request. Tax considerations with options transactions are unique and investors considering options should consult their tax advisor as to how taxes affect the outcome of each options strategy.

Options Order Flow Rebates.
If you are enrolled in our Options Order Flow Rebate Program, Public Investing will share a percentage of our estimated order flow revenue for each completed options trade as a rebate to help reduce your trading costs. Rebate rates vary monthly from $0.06-$0.18 and depend on your current and prior month’s options trading volume. This rebate will be deducted from your cost to place the trade and will be reflected on your trade confirmation. To learn more, see our Options Rebate Program Terms & Conditions, Order Rebate FAQ and Fee Schedule.

Bonds.
“Bonds” shall refer to corporate debt securities and U.S. government securities offered on the Public platform through a self-directed brokerage account held at Public Investing and custodied at Apex Clearing. For purposes of this section, Bonds exclude treasury securities held in treasury accounts with Jiko Securities, Inc. as explained under the “ Treasury Accounts” section.

Investments in Bonds are subject to various risks including risks related to interest rates, credit quality, market valuations, liquidity, prepayments, early redemption, corporate events, tax ramifications and other factors. The value of Bonds fluctuate and any investments sold prior to maturity may result in gain or loss of principal. In general, when interest rates go up, Bond prices typically drop, and vice versa. Bonds with higher yields or offered by issuers with lower credit ratings generally carry a higher degree of risk. All fixed income securities are subject to price change and availability, and yield is subject to change. Bond ratings, if provided, are third party opinions on the overall bond's credit worthiness at the time the rating is assigned. Ratings are not recommendations to purchase, hold, or sell securities, and they do not address the market value of securities or their suitability for investment purposes.

A Bond Account is a self-directed brokerage account with Public Investing. Deposits into this account are used to purchase 10 investment-grade and high-yield bonds. The Bond Account’s yield is the average, annualized yield to worst (YTW) across all ten bonds in the Bond Account, before fees. A bond’s yield is a function of its market price, which can fluctuate; therefore a bond’s YTW is not “locked in” until the bond is purchased, and your yield at time of purchase may be different from the yield shown here. The “locked in” YTW is not guaranteed; you may receive less than the YTW of the bonds in the Bond Account if you sell any of the bonds before maturity or if the issuer defaults on the bond. Public Investing charges a markup on each bond trade. See our Fee Schedule.

Bond Accounts are not recommendations of individual bonds or default allocations. The bonds in the Bond Account have not been selected based on your needs or risk profile. You should evaluate each bond before investing in a Bond Account. The bonds in your Bond Account will not be rebalanced and allocations will not be updated, except for Corporate Actions.

Fractional Bonds also carry additional risks including that they are only available on Public and cannot be transferred to other brokerages. Read more about the risks associated with fixed income and fractional bonds. See Bond Account Disclosures to learn more.

High-Yield Cash Account.
A High-Yield Cash Account is a secondary brokerage account with Public Investing. Funds in your High-Yield Cash Account are automatically deposited into partner banks (“Partner Banks”), where that cash earns interest and is eligible for FDIC insurance. See here for a list of current Partner Banks. Your Annual Percentage Yield is variable and may change at the discretion of the Partner Banks or Public Investing. Apex Clearing and Public Investing receive administrative fees for operating this program, which reduce the amount of interest paid on swept cash. Neither Public Investing nor any of its affiliates is a bank. Learn more.

Cryptocurrency.
Cryptocurrency trading, execution, and custody services are provided by Bakkt Crypto Solutions, LLC (NMLS ID 1828849) (“Bakkt”). Cryptocurrency is highly speculative, involves a high degree of risk, and has the potential for loss of the entire amount of an investment. Cryptocurrencies offered by Bakkt are not securities and are not FDIC insured or protected by SIPC. Your cryptocurrency assets are held in your Bakkt account. Bakkt is a licensed virtual currency business by the New York State Department of Financial Services and a licensed money transmitter, but is not a registered broker-dealer or a FINRA member. Your Bakkt Crypto account is separate from your brokerage account with Public Investing, which holds US-listed stocks and ETFs. Please review the Risk Disclosures before trading.

Treasury Accounts.
Investing services in treasury accounts offering 6 month US Treasury Bills on the Public platform are through Jiko Securities, Inc. (“JSI”), a registered broker-dealer and member of FINRA & SIPC. See JSI’s FINRA BrokerCheck and Form CRS for further information. JSI uses funds from your Treasury Account to purchase T-bills in increments of $100 “par value” (the T-bill’s value at maturity). T-bills are purchased at a discount to the par value and the T-bill’s yield represents the difference in price between the “par value” and the “discount price.” Aggregate funds in your Treasury Account in excess of the T-bill purchases will remain in your Treasury Account as cash. The value of T-bills fluctuate and investors may receive more or less than their original investments if sold prior to maturity. T-bills are subject to price change and availability - yield is subject to change. Past performance is not indicative of future performance. Investments in T-bills involve a variety of risks, including credit risk, interest rate risk, and liquidity risk. As a general rule, the price of a T-bills moves inversely to changes in interest rates. Although T-bills are considered safer than many other financial instruments, you could lose all or a part of your investment. See Jiko U.S. Treasuries Risk Disclosures for further details.

Investments in T-bills: Not FDIC Insured; No Bank Guarantee; May Lose Value.

Banking services and bank accounts are offered by Jiko Bank, a division of Mid-Central National Bank. JSI and Jiko Bank are not affiliated with Public Holdings, Inc. (“Public”) or any of its subsidiaries. None of these entities provide legal, tax, or accounting advice. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Commission-free trading refers to $0 commissions charged on trades of US listed registered securities placed during the US Markets Regular Trading Hours in self-directed brokerage accounts offered by Public Investing. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Public’s Investing’s Fee Schedule to learn more.

Fractional shares are illiquid outside of Public and not transferable. For a complete explanation of conditions, restrictions and limitations associated with fractional shares, see our Fractional Share Disclosure to learn more.

Investment Plans. Investment Plans (“Plans”) shown in our marketplace are for informational purposes only and are meant as helpful starting points as you discover, research and create a Plan that meets your specific investing needs. Plans are self-directed purchases of individually-selected assets, which may include stocks, ETFs and cryptocurrency. Plans are not recommendations of a Plan overall or its individual holdings or default allocations. Plans are created using defined, objective criteria based on generally accepted investment theory; they are not based on your needs or risk profile. You are responsible for establishing and maintaining allocations among assets within your Plan. Plans involve continuous investments, regardless of market conditions. Diversification does not eliminate risk. See our Investment Plans Terms and Conditions and Sponsored Content and Conflicts of Interest Disclosure.

Alpha.
Alpha is an experiment brought to you by Public Holdings, Inc. (“Public”). Alpha is an AI research tool powered by GPT-4, a generative large language model. Alpha is experimental technology and may give inaccurate or inappropriate responses. Output from Alpha should not be construed as investment research or recommendations, and should not serve as the basis for any investment decision. All Alpha output is provided “as is.” Public makes no representations or warranties with respect to the accuracy, completeness, quality, timeliness, or any other characteristic of such output. Your use of Alpha output is at your sole risk. Please independently evaluate and verify the accuracy of any such output for your own use case.

Market Data.
Quotes and other market data for Public’s product offerings are obtained from third party sources believed to be reliable, but Public makes no representation or warranty regarding the quality, accuracy, timeliness, and/or completeness of this information. Such information is time sensitive and subject to change based on market conditions and other factors. You assume full responsibility for any trading decisions you make based upon the market data provided, and Public is not liable for any loss caused directly or indirectly by your use of such information. Market data is provided solely for informational and/or educational purposes only. It is not intended as a recommendation and does not represent a solicitation or an offer to buy or sell any particular security.